Impact of an Electronic Pain and Opioid Risk Assessment Program: Are There Improvements in Patient Encounters and Clinic Notes?

Objective. A comprehensive electronic self-report assessment, called PainCAS® (Clinical Assessment System), was developed and implemented in three clinics. PainCAS captures demographic information, pain assessment, quality-of-life variables, and contains validated, electronic versions of screeners f...

Full description

Saved in:
Bibliographic Details
Published inPain medicine (Malden, Mass.) Vol. 17; no. 11; pp. 2047 - 2060
Main Authors Butler, Stephen F., Zacharoff, Kevin L., Charity, Sadaf, Black, Ryan A., Chung, Emma, Barreveld, Antje, Clark, Molly S., Jamison, Robert N.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective. A comprehensive electronic self-report assessment, called PainCAS® (Clinical Assessment System), was developed and implemented in three clinics. PainCAS captures demographic information, pain assessment, quality-of-life variables, and contains validated, electronic versions of screeners for risk of aberrant opioid-related behaviors (the SOAPP and COMM). This investigation sought to determine the impact of PainCAS on documentation of pain and opioid risk evaluations. Exploratory hypotheses examined changes in the content of the patient-provider interaction and any impact on outcome. Methods. In study 1, chart reviews were conducted between pain patients who completed the electronic program (N = 89) and controls who represented standard of care (N = 120). In study 2, two groups of chronic pain patients (treatment-as-usual Control condition = 75, PainCAS Experimental condition = 72) were interviewed after completing their index clinic visit and completed mailed questionnaires 3 months later. Results. Results revealed significantly more key, pain-relevant chart elements documented in charts of patients who completed the PainCAS than those using a traditional paper questionnaire (Study 1; <0.001). In Study 2, the Experimental group reported more discussion about legal issues, substance use history, and medication safety compared with the Control group (p < 0.05). Satisfaction questionnaire responses supported provider and patient perceived benefit from using PainCAS. However, as expected, no differences were found between conditions on outcome measures of pain, mood, and function. Conclusions. Results indicate that use of the PainCAS electronic pain assessment improves documentation of chart elements in clinic notes and is associated with increased discussion of key, pain-relevant topics during the clinical visit.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Funding sources: This work was supported by the National Institute on Drug Abuse (NIDA) Small Business Innovative Research (SBIR) program (1R43DA026359 and 2R44DA026359 Butler [PI]).
Disclosure and conflicts of interest: Butler, Zacharoff, Charity, Black and Chung are employees of Inflexxion, which holds the copyright for the PainCAS® software as well as the SOAPP® and COMM® measures. There are no other conflicts of interest to report.
ISSN:1526-2375
1526-4637
DOI:10.1093/pm/pnw033